MetaVia Inc.

MTVA | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.67

$0 (0.00%)

Sep 22, 2026, 1:19 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.00%

(1D)

Rating

Updated: Sep 19, 2026

33.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $3.67M

1D Range

1.65 1.67

52W Range

0.97 14.85

Valuation (TTM)

PE -0.41

PB 0.54

EV/EBITDA 0.61

Valuation (NTM)

Forward PE N/A

Forward PEG 0.07

Price Target $20

Cash Flow

FCF Yield -430.7%

SBC Adj. FCF Yield -441.5%

SBC Impact -2.5%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 97.0% | 86.5%

FCF 3Y | 5Y 11.3% | -10.4%

Returns

ROA -108.8%

ROE -209.7%

ROIC -213.3%

Financial Health

Net Cash

$12.63M

Current Ratio 2.06

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a clinical-stage biotechnology company with a core focus on discovering and commercializing novel pharmaceutical solutions for cardi...

Sector Healthcare

Industry Biotechnology

Employees 8

IPO Date Aug 4, 2016

Website www.metaviatx.com

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$20

Upside

+1097.60%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞